BBIO(BBIO)
BBIO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $961M | $1.60B | $2.48B | $3.57B | $4.50B |
| Low | $929M | $1.35B | $2.05B | $3.12B | $3.94B |
| High | $994M | $1.81B | $3.12B | $4.12B | $5.20B |
| EBITDA Avg | $-961M | $-1.60B | $-2.48B | $-3.57B | $-4.50B |
| Low | $-994M | $-1.81B | $-3.12B | $-4.12B | $-5.20B |
| High | $-929M | $-1.35B | $-2.05B | $-3.12B | $-3.94B |
| EBIT Avg | $-961M | $-1.60B | $-2.48B | $-3.57B | $-4.50B |
| Low | $-994M | $-1.81B | $-3.12B | $-4.12B | $-5.20B |
| High | $-929M | $-1.35B | $-2.05B | $-3.12B | $-3.94B |
| Net Income Avg | $-429M | $119M | $767M | $1.54B | $2.05B |
| Low | $-624M | $-2.47B | $-5M | $1.29B | $1.72B |
| High | $-290M | $4.17B | $1.42B | $1.85B | $2.46B |
| EPS Avg | $-2.23 | $0.58 | $3.84 | $7.80 | $10.41 |
| Low | $-3.16 | $-12.55 | $-0.02 | $6.53 | $8.72 |
| High | $-1.47 | $21.14 | $7.19 | $9.36 | $12.49 |
| Analysts (Rev / EPS) | 14 / 11 | 14 / 11 | 15 / 13 | 10 / 10 | 7 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $252M | $294M | $309M | $357M | $410M | $467M | $498M | $555M |
| Low | $244M | $261M | $288M | $333M | $382M | $435M | $464M | $517M |
| High | $261M | $369M | $347M | $401M | $461M | $525M | $560M | $624M |
| EBITDA Avg | $-252M | $-294M | $-309M | $-357M | $-410M | $-467M | $-498M | $-555M |
| Low | $-261M | $-369M | $-347M | $-401M | $-461M | $-525M | $-560M | $-624M |
| High | $-244M | $-261M | $-288M | $-333M | $-382M | $-435M | $-464M | $-517M |
| EBIT Avg | $-252M | $-294M | $-309M | $-357M | $-410M | $-467M | $-498M | $-555M |
| Low | $-261M | $-369M | $-347M | $-401M | $-461M | $-525M | $-560M | $-624M |
| High | $-244M | $-261M | $-288M | $-333M | $-382M | $-435M | $-464M | $-517M |
| Net Income Avg | $-96M | $-62M | $-47M | $-9M | $36M | $80M | $101M | $151M |
| Low | $-140M | $-70M | $-55M | $-10M | $33M | $73M | $92M | $137M |
| High | $-67M | $-53M | $-43M | $-8M | $42M | $93M | $117M | $175M |
| EPS Avg | $-0.49 | $-0.32 | $-0.24 | $-0.04 | $0.18 | $0.41 | $0.52 | $0.77 |
| Low | $-0.71 | $-0.36 | $-0.28 | $-0.05 | $0.17 | $0.37 | $0.47 | $0.70 |
| High | $-0.34 | $-0.27 | $-0.22 | $-0.04 | $0.21 | $0.47 | $0.60 | $0.89 |
| Analysts (Rev / EPS) | 9 / 5 | 13 / 4 | 6 / 1 | 6 / 1 | 6 / 1 | 6 / 1 | 5 / 2 | 5 / 2 |